Brief: GeneOne Life Science says U.S. food and drug administration has cleared first-in-human clinical study of its collaborative vaccine for MERS
Nov 19 (Reuters) - GeneOne Life Science Inc 011000.KS : * U.S. food and drug administration has cleared the first-in-human clinical study of its collaborative vaccine for mers * Co and Inovio Pharmaceuticals Co developing vaccine and plan to initiate first human trial of mers vaccine before end of year * Source text for Eikon ID:nGNXMDTTYa * Further company coverage 011000.KS ((Bengaluru Newsroom; +1 646 223 8780))